 |
 |
 |
| Day 1: Thursday 29th May 2008 |
| |
|
|
| 08:30 |
|
Registration and refreshments |
| |
|
|
| 09:00 |
|
Chairman's opening remarks |
| |
|
|
| 09:15 |
|
Identifying and applying innovative tools
to maximise the quality and efficiency of your manufacturing process
- Evaluating the solutions that guarantee lower expenditure, premium
quality and shorter lead-times
- Reviewing how successfully Lean and Six Sigma have been applied
in pharmaceutical and bio manufacturing environments
- Assessing the impact of outsourcing on quality and productivity
standards
- Driving and maintaining quality when working across a diverse
product portfolio
Greg Watts, Manufacturing Improvement Manager
PROCESS INDUSTRIES CENTRE FOR MANUFACTURING
EXCELLENCE (PICME) |
| |
|
|
| 10:00 |
|
Integrating knowledge management with
process understanding, Quality by Design and PAT
- Applying PAT, GMP, QBD guidelines and determining where they
fit in your production plans
- Determining the potential of knowledge management models and
how they can be leveraged to drive operational success
- Pinpointing where the major challenges lie in implementing
QBD and PAT starting from the R&D practical framework
- Evaluating the important differences between traditional and
Quality by Design (QBD) development environments
Jean-Marie Geoffroy, Director, Pharmaceutical
Development
TAP PHARMACEUTICALS |
| |
|
|
| 10:45 |
|
Networking coffee break |
| |
|
|
| 11:15 |
|
Tackling the major challenges of implementing
PAT into your existing infrastructure for improved quality results
- Evaluating the best ways to introduce PAT into your facility
- Choosing the best infrastructure to accommodate PAT integration
- Effectively planning which facilities are best to prioritize
PAT and then how to phase it in to the rest of your facilities
- How to use PAT to release Lean thinking
Tom Cochrane, Business Process Development Manager
NAPP PHARMACEUTICALS |
| |
|
|
| 12:00 |
|
Developing a flawless integrated quality
risk management strategy to eliminate the threat of emerging vulnerabilities
- Re-designing your risk management approach with emphasis on
the root stages to better offset weaknesses
- Identifying the key applications of advanced methods for process
design/control and for process improvement
- Effectively communicating your risk management plan to partners
to ensure seamless quality controls
- Experiences of process design and control and process improvement
Marco Lupo, Advanced Methods, Process & Methods
Manager GPSG EMEA
JOHNSON & JOHNSON ITALY |
| |
|
|
| 12:45 |
|
Networking lunch |
| |
|
|
| 13:45 |
|
Applying risk management and quality control
standards that are specific to biopharmaceutical products
- Understanding the complexities of quality control when manufacturing
bio products and fermentation
- Determining the quality constraints of high volume bio manufacturing
- What aspects of the risk management process need to be enhanced?
- Evaluating novel technological approaches to drive quality
and efficiency
- Applying Lean and Six Sigma in bulk biopharmaceutical production
Cynthia Wooge, Manager, Process Development
SAFC PHARMA |
| |
|
|
| 14:30 |
|
Striking the balance between quality and
efficiency when manufacturing a diverse product portfolio
- Standardising quality objectives across different manufacturing
processes
- Making the most of technology to help streamline multiple production
facilities with different chemical compounds and quality standards
- Up skilling your workforce to ensure quality standards are
maintained in a multi-production facility
- Utilising key tools such as metrics and trending of quality
data to monitor the success of your systems
Mathew Cherian, Senior Technical Director
PATHEON PHARMACEUTICAL SERVICES |
| |
|
|
| 15:15 |
|
Networking coffee |
| |
|
|
| 15:45 |
|
Effectively linking your manufacturing process
improvement with the wider supply chain
- What do PAT, QBD and Lean Six Sigma mean in R&D?
- Is PAT really Lean?
- Aligning the unique quality and design elements from R&D
to your manufacturing process design
- Determining the differences in manufacturing excellence to
R&D
- How to ensure your operational excellence and quality control
systems from R&D to manufacturing continue to function effectively
Rachel Brody, Principal Scientist, Process Analytical
Technology
PFIZER GLOBAL |
| |
|
|
| 16:30 |
|
Quality and productivity control zone –
roundtable discussion and debates
Take this chance to come together to discuss and debate the latest
issues around quality control and Lean process implementation to
enhance the productivity and excellence of your facility. This roundtable
will gather the key speakers and topics of the day and allow you
to put crucial questions to the speaker on the roundtable of your
choice. Roundtable discussion sessions cover:
- Regulatory issues and their impact on your facility
- Implementing robust risk management tools
- The unique challenges for biopharmaceutical manufacturing
- Designing and implementing Lean Six Sigma
- Achieving successful data integration
- Using outsourcing as a tool for improved quality control and
operational efficiency
|
| |
|
|
| 17:30 |
|
End of day one |
| |
|
|
| Day 1: Friday 30th May 2008 |
| |
|
|
| 08:30 |
|
Chairman’s opening remarks |
| |
|
|
| 08:45 |
|
Implementing Six Sigma and Lean manufacturing
in a complex and constantly changing supply chain
- Identifying the key factors that have inhibited the full success
of Lean Six Sigma implementation
- Determining key infrastructure requirements to ensure successful
Lean Six Sigma implementation
- Combining Lean Six Sigma with PAT to maximise quality and efficiency
- Building flexibility into your structures to support fluctuations
in production
Dr. Fadel Hamed, Head of Operational Excellence
GENENTECH, INC. |
| |
|
|
| 09:30 |
|
Maintaining your compliance standards through
strategic integration of Lean Six Sigma
- Understanding your compliance standards and its cost impact
on your facilities
- How to best make use of your facilities to further quality
and productivity by integrating Lean Six Sigma with compliance
- Integrating the supplier development process into the business
process excellence scheme
- Identifying the most effective compliance process and understanding
how it relates to compliance standards
Dr Siegfried Schmitt, Principal Consultant
PAREXEL CONSULTING |
| |
|
|
| 10:15 |
|
Networking coffee break |
| |
|
|
| 10:45 |
|
Extending your quality and efficiency standards
to your outsourcing partners
- Establishing the rate of growth in contract manufacturing and
its implications for quality control
- Examining how CMOs are pro-actively driving quality and performance
standards in their facilities
- Harmonising your production targets to improve reliability
- How to further extend your standards when working with third
party alliances
Dr Ranjana Pathak, Vice President Quality Assurance
ENDO PHARMACEUTICALS |
| |
|
|
| 11:30 |
|
Best practices for improving lead time of
technology transfer to contract manufacturing organization
- Identifying key barriers to effective relationship management
and quality control
- Determining optimal KPIs and monitoring systems for managing
partner performance
- Communicating and transferring your key end project goals to
maintain quality and operational excellence
Dr. Nkere Ebube, Director, Technical Operations
ALPHARMA PHARMACEUTICALS |
| |
|
|
| 12:15 |
|
Networking lunch |
| |
|
|
| 13:15 |
|
Facilitating rapid skills and technology
transfer to outsourcing partners to maintain quality and efficiency
- Evaluating the most cost effective methods of achieving rapid
transfer e.g. virtual plants
- What processes and skills transfer are necessary to ensure
operational excellence?
- Ensuring the most effective technology transfer process to
guarantee stability and high product quality
Cristina Vale, Senior Process Engineer
AVECIA |
| |
|
|
| 14:00 |
|
Panel session: Minimising risk and maximising
manufacturing quality when outsourcing abroad
- Key factors to consider when selecting partners abroad
- Benchmarking quality and regulatory standards between Europe
and emerging markets
- Adopting appropriate monitoring systems to achieve quality
and efficiency from emerging market partners
- Lessons learnt from emerging market case studies to date
Panellists include:
Jacques Navellou, Senior Director External Manufacturing
SANOFI PASTEUR
Dr. Nkere Ebube, Director, Technical Operations
ALPHARMA PHARMACEUTICALS
Dr. Ranjana Pathak, Vice President Quality Assurance
ENDO PHARMACEUTICALS |
| |
|
|
| 14:45 |
|
Networking coffee break |
| |
|
|
| 15:15 |
|
The importance of Six Sigma implementation
in a strong expansion phase
- Why Six Sigma really can help in an expansion phase
- The Schott Six-Sigma concept
- A case study from a supplier of the pharmaceutical industry
Dr. Alexander Huber, Head of Production
SCHOTT SCHWEIZ AG |
| |
|
|
| 16:00 |
|
Improving process productivity and quality
input through the motivation of people in pharmaceutical and bio
manufacturing facilities
- How to effectively improve process productivity by reducing
cycle times of releases and bottlenecks in QC and testing
- Utilising key tools such as metrics and trending of quality
data to monitor the success of your process and increase quality
output
- Clarifying the key role people play in delivering productivity
and quality within the facility
- The best approaches to increasing staff motivation and decreasing
frustration with complex systems and processes
Massimo Appiotti, Partner
VALEOCON MANAGEMENT CONSULTING |
| |
|
|
| 16:45 |
|
Close of conference |